Gladstone NOW: The Campaign Join Us on the Journey ✕
151 - 165 of 246 Results Clear All
Finding reveals achilles’ heel easily targeted with existing drugs
COVID-19 Infectious Disease Krogan Lab
Screening potential COVID-19 drug therapies through lung organoids promises a faster pipeline to approved treatments.
Gladstone Experts COVID-19 Infectious Disease Krogan Lab Ott Lab Organoids
Unexpected partnerships and supporters emerge to aid biomedical research.
Philanthropy Donor Stories COVID-19 Infectious Disease
San Francisco Chronicle—Gladstone Senior Investigators Melanie Ott and Warner Greene explain the potential risks and benefits of steroid treatments for COVID-19 patients.
Gladstone Experts COVID-19 Center for HIV Cure Research Infectious Disease Greene Lab Ott Lab
San Francisco Chronicle—Melanie Ott, MD, PhD, director of the Gladstone Institute of Virology, comments on the recent report that dexamethasone, a common anti-inflammatory drug, reduces the death rate of severely ill COVID-19 patients by one third.
Gladstone Experts COVID-19 Infectious Disease Ott Lab
HIV establishes latency by co-opting a cellular stress pathway
News Release Research (Publication) Flow Cytometry Core HIV/AIDS Infectious Disease Ott Lab
Melanie Ott tackles emerging viruses and infectious diseases at the helm of the new Gladstone Institute of Virology
History Institutional News COVID-19 Infectious Disease Ott Lab
This girl scout troop is helping find a solution for the pandemic.
Office of the President Philanthropy Donor Stories COVID-19 Infectious Disease Greene Lab
The New York Times—Melanie Ott, MD, PhD, director of the Gladstone Institute of Virology, is one of the virologists prominently featured in this detailed account of the COVID-19 pandemic and of scientists’ efforts to understand and fight the coronavirus.
Gladstone Experts COVID-19 Infectious Disease Ott Lab
San Francisco Chronicle—Wearing a mask is increasingly mandated by businesses and local jurisdictions, but some people have refused to comply. Senior Investigator Warner Greene explains that since the coronavirus is spread by respiratory droplets, a mask is an extremely effective way to reduce transmission.
Gladstone Experts COVID-19 Infectious Disease Greene Lab
SF Business Times—Melanie Ott, director of the Gladstone Institute of Virology, was recently named one of the most influential women in Bay Area business by the San Francisco Business Times. She reflects on the similarities between the AIDS crisis and the current COVID-19 pandemic, and describes how her lab has refocused their efforts on the novel virus.
Gladstone Experts COVID-19 Infectious Disease Ott Lab
HIV remodels its target cells, facilitating spread from the female reproductive tract to the rest of the body, shows a new study at Gladstone Institutes.
News Release Research (Publication) HIV/AIDS Center for HIV Cure Research Infectious Disease Roan Lab Disease Models Single Cell
When Science Speaks Podcast—Senior Investigator Warner Greene shares his team’s plan to screen FDA-approved drugs to find those that could be repurposed to fight COVID-19.
Gladstone Experts COVID-19 Infectious Disease Greene Lab
The Mercury News—Scientists are racing to develop and test vaccines to protect people against COVID-19, and clinical trials to determine the efficacy of one leading vaccine candidate are scheduled to begin in July. Melanie Ott, director of the Gladstone Institute of Virology, explained that vaccine development is a lengthy process, and the development of effective therapeutics may come before a vaccine is widely available.
Gladstone Experts COVID-19 Infectious Disease Ott Lab
Inverse—A new study shows that speaking loudly can release droplets that contain coronavirus and have the potential to remain airborne for up to 14 minutes. Senior Investigator Warner Greene explains that any amount of the virus has the potential to cause infection.
Gladstone Experts COVID-19 Infectious Disease Greene Lab
